Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mitomycin"" wg kryterium: Temat


Tytuł:
A Secreted BBE-Like Enzyme Acting as a Drug-Binding Efflux Carrier Confers Microbial Self-Resistance to Mitomycin C.
Autorzy:
Chen X; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
He R; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Sun A; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Pu J; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Pan HX; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.; State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
Tang GL; School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.; State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
Pokaż więcej
Źródło:
Organic letters [Org Lett] 2024 Feb 16; Vol. 26 (6), pp. 1233-1237. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mitomycin*/pharmacology
Mitomycin*/metabolism
NAD(P)H Dehydrogenase (Quinone)*/metabolism
Oxidoreductases/metabolism ; Oxidoreductases, N-Demethylating/metabolism
Czasopismo naukowe
Tytuł:
Comparison of the safety and efficacy of Mitomycin C 0.02% used intra-operatively by subconjunctival injection versus direct scleral application using sponges in phacotrabeculectomy: A prospective randomized controlled trial.
Autorzy:
Agarwal N; Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Krishna TS; Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Simha RA; Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Braganza AD; Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Gowri M; Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India.
Abraham LM; Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Mar 01; Vol. 72 (3), pp. 402-407. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Mitomycin*
Trabeculectomy*/methods
Humans ; Alkylating Agents ; Treatment Outcome ; Prospective Studies ; Intraocular Pressure
Czasopismo naukowe
Tytuł:
Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.
Autorzy:
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: .
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Nov; Vol. 84 (5), pp. 512-513. Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Comment
MeSH Terms:
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Antibiotics, Antineoplastic/therapeutic use ; Administration, Intravesical ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/drug therapy
Czasopismo naukowe
Tytuł:
Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
Autorzy:
Moschini M; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: .
Salonia A; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Briganti A; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Montorsi F; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Oct; Vol. 84 (4), pp. 439-440. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Comment
MeSH Terms:
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Neoadjuvant Therapy ; Prospective Studies ; Transurethral Resection of Bladder ; Treatment Outcome ; Administration, Intravesical ; Neoplasm Invasiveness/pathology ; Antibiotics, Antineoplastic ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
Evaluation of the effects of ethanol and mitomycin on survival of rat limbal stem cells: an in vitro study.
Autorzy:
Bayati V; Cellular and Molecular Research Center, Medical Basic Sciences Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Department of Anatomical Sciences, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nasrolahi A; Infectious Ophthalmologic Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Zamani M; Infectious Ophthalmologic Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nejaddehbashi F; Cellular and Molecular Research Center, Medical Basic Sciences Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. fereshte_.; Infectious Ophthalmologic Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. fereshte_.
Pokaż więcej
Źródło:
International ophthalmology [Int Ophthalmol] 2023 Jul; Vol. 43 (7), pp. 2503-2512. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*/pharmacology
Mitomycin*/therapeutic use
Corneal Diseases*
Male ; Rats ; Animals ; Ethanol/pharmacology ; Limbal Stem Cells ; Rats, Wistar
Czasopismo naukowe
Tytuł:
Two-stage intra-tenon injection versus sponge-applied mitomycin C-augmented trabeculectomy: a one-year study.
Autorzy:
Shih EJ; Department of Ophthalmology, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1St Road, Zuoying District, Kaohsiung City, 81362, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Chen YY; Department of Ophthalmology, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1St Road, Zuoying District, Kaohsiung City, 81362, Taiwan. .; School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan. .; Shu-Zen Junior College of Medicine and Management, Kaohsiung City, Taiwan. .
Pokaż więcej
Źródło:
International ophthalmology [Int Ophthalmol] 2023 Aug; Vol. 43 (8), pp. 2593-2603. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*
Trabeculectomy*/methods
Humans ; Retrospective Studies ; Antiglaucoma Agents ; Follow-Up Studies ; Intraocular Pressure ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Sequential Treatment With Bacillus Calmette-Güerin (BCG) and Mitomycin C Administered With Electromotive Drug Administration (EMDA) in Patients With High-Risk Nonmuscle Invasive Bladder Cancer After BCG Failure.
Autorzy:
Sanz Gómez I; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain. Electronic address: .
Huguet J; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Bravo A; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Robalino J; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Rodríguez Faba Ó; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Territo Á; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Gaya JM; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Palou J; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Breda A; Department of Urology, Oncology Urology Unit, Fundació Puigvert, Universitat Autònoma de Barcelona, Spain.
Pokaż więcej
Źródło:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Aug; Vol. 21 (4), pp. e286-e290. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*/administration & dosage
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Aged ; Humans ; Administration, Intravesical ; BCG Vaccine/administration & dosage ; BCG Vaccine/therapeutic use ; Immunotherapy ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/chemically induced ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Delayed presentation of surgically induced scleral necrosis after I-BRITE procedure treated with immunosuppressive therapy.
Autorzy:
Azar NS; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.
Ruiz-Lozano RE; Tecnologico de Monterrey, School of M and Health Sciences, Institute of Ophthalmology and Visual Sciences, Monterrey, Mexico.
Quiroga-Garza ME; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.
Soifer M; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Mousa HM; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.
Komai S; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.
Leverenz DL; Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, North Carolina.
Perez VL; Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina.
Pokaż więcej
Źródło:
Digital journal of ophthalmology : DJO [Digit J Ophthalmol] 2023 Sep 30; Vol. 29 (3), pp. 77-82. Date of Electronic Publication: 2023 Sep 30 (Print Publication: 2023).
Typ publikacji:
Case Reports
MeSH Terms:
Mitomycin*/therapeutic use
Sclera*/surgery
Female ; Humans ; Adult ; Conjunctiva/surgery ; Necrosis/etiology ; Immunosuppression Therapy
Raport
Tytuł:
Applications of Mitomycin C in Cornea and External Disease.
Autorzy:
Crespo MA; Wills Eye Hospital, Cornea Service, Philadelphia, USA.
Rapuano CJ; Wills Eye Hospital, Cornea Service, Philadelphia, USA.
Syed ZA; Wills Eye Hospital, Cornea Service, Philadelphia, USA.
Pokaż więcej
Źródło:
Turkish journal of ophthalmology [Turk J Ophthalmol] 2023 Jun 21; Vol. 53 (3), pp. 175-182.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Mitomycin*/therapeutic use
Photorefractive Keratectomy*/methods
Humans ; Lasers, Excimer ; Cornea/surgery
Czasopismo naukowe
Tytuł:
Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors.
Autorzy:
Chang R; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Fu R; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Huang Y; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China.
Zhang J; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Feng C; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Wang R; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Yan H; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Li G; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Chu X; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Yuan F; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng 252000, China.; School of Clinical Medicine, Shandong University, Jinan 250012, China.
Jia D; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Li J; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.
Pokaż więcej
Źródło:
Molecular pharmaceutics [Mol Pharm] 2023 Jun 05; Vol. 20 (6), pp. 2864-2875. Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liposomes*/chemistry
Liposomes*/pharmacology
Mitomycin*/pharmacology
Recombinant Fusion Proteins*/pharmacology
TNF-Related Apoptosis-Inducing Ligand*/pharmacology
Nanoparticles*/chemistry
Cell Line, Tumor ; Humans
Czasopismo naukowe
Tytuł:
Cancer stem cell fate determination: mito-nuclear communication.
Autorzy:
Fan M; School of Basic Medical Sciences, Medical College of Yan'an University, Yanan, 716000, China.; Department of Cell Biology, National Translational Science Center for Molecular Medicine, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi'an, 710032, China.
Shi Y; Department of Cell Biology, National Translational Science Center for Molecular Medicine, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi'an, 710032, China.
Zhao J; School of Basic Medical Sciences, Medical College of Yan'an University, Yanan, 716000, China. .
Li L; Department of Cell Biology, National Translational Science Center for Molecular Medicine, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2023 Jun 27; Vol. 21 (1), pp. 159. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Video-Audio Media; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Mitomycin*/metabolism
Humans ; Cell Differentiation ; Mitochondria/metabolism ; Neoplastic Stem Cells/metabolism ; Reactive Oxygen Species/metabolism
Czasopismo naukowe
Tytuł:
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
Autorzy:
Busetto GM; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy. .
Finati M; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Chirico M; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Cinelli F; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
D'Altilia N; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Falagario UG; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Sanguedolce F; Department of Pathology, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Del Giudice F; Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome, Italy.
De Berardinis E; Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome, Italy.
Ferro M; Department of Urology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.
Crocetto F; Department of Urology, University of Naples Federico II, Naples, Italy.
Porreca A; Oncological Urology, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
Di Gianfrancesco L; Oncological Urology, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
Calo' B; Bonomo Teaching Hospital, Andria, BAT, Italy.
Mancini V; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Bettocchi C; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Carrieri G; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.
Cormio L; Department of Urology, University of Foggia, Policlinico Riuniti, Via Luigi Pinto, 1, 71122, Foggia, Italy.; Bonomo Teaching Hospital, Andria, BAT, Italy.
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 May; Vol. 41 (5), pp. 1329-1335. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Humans ; BCG Vaccine/therapeutic use ; Conservative Treatment ; Combined Modality Therapy ; Administration, Intravesical ; Neoplasm Invasiveness ; Adjuvants, Immunologic/therapeutic use ; Neoplasm Recurrence, Local/drug therapy
Czasopismo naukowe
Tytuł:
Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00470.
Autorzy:
Pradere B; Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, France; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Basile G; Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
Seisen T; Department of Urology, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, GRC 5, Predictive Onco-Urology, Paris, France. Electronic address: .
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Apr; Vol. 83 (4), pp. e105-e106. Date of Electronic Publication: 2023 Jan 28.
Typ publikacji:
Randomized Controlled Trial; Letter; Comment
MeSH Terms:
Mitomycin*
Urinary Bladder Neoplasms*
Humans
Raport
Tytuł:
Reply to Benjamin Pradere, Giuseppe Basile, and Thomas Seisen's Letter to the Editor re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol 2023;41:2,206-11.
Autorzy:
Lindgren MS; Department of Urology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: .
Jensen JB; Department of Urology, Aarhus University Hospital, Aarhus, Denmark; Department of Urology, Regional Hospital West Jutland, Holstebro, Denmark; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
European urology [Eur Urol] 2023 Apr; Vol. 83 (4), pp. e107-e108. Date of Electronic Publication: 2023 Jan 28.
Typ publikacji:
Randomized Controlled Trial; Letter; Comment
MeSH Terms:
Mitomycin*
Urinary Bladder Neoplasms*
Humans
Raport
Tytuł:
Two routes of administration of mitomycin C in a trabeculectomy.
Autorzy:
Pillai M; Aravind Eye Hospital, Glaucoma Department, Madurai, Tamil Nadu, India.
Kalegore AA; Aravind Eye Hospital, Glaucoma Department, Madurai, Tamil Nadu, India.
Mathews AM; Aravind Eye Hospital, Glaucoma Department, Madurai, Tamil Nadu, India.
Krishnadas SR; Aravind Eye Hospital, Glaucoma Department, Madurai, Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Feb; Vol. 71 (2), pp. 673-674.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*
Trabeculectomy*/methods
Humans ; Intraocular Pressure ; Treatment Outcome ; Tonometry, Ocular
Czasopismo naukowe
Tytuł:
Insight Into Factors Governing Formation, Synthesis and Stereochemical Configuration of DNA Adducts Formed by Mitomycins.
Autorzy:
Paz MM; Instituto de Materiais (iMATUS), Departamento de Química Orgánica, Facultad de Química, Universidade de Santiago de Compostela, Santiago de Compostela, A Coruña, 15782, Spain.
Champeil E; Department of sciences, John Jay College of Criminal Justice, 524 West 59th street, New York, NY, 10019, United States.; Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY, 10016, United States.
Pokaż więcej
Źródło:
Chemical record (New York, N.Y.) [Chem Rec] 2023 Jan; Vol. 23 (1), pp. e202200193. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
DNA Adducts*
Mitomycin*/pharmacology
Mitomycin*/chemistry
Mitomycin*/metabolism
DNA/chemistry ; Oligonucleotides
Czasopismo naukowe
Tytuł:
Optimization of bovine embryonic fibroblast feeder layer prepared by Mitomycin C.
Autorzy:
Zhao F; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Yu J; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Ding Q; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Chen K; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Xia S; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Qian Y; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China.
Gao Y; Shandong OX Livestock Breeding Co.,Ltd, Jinan, 250100, Shandong, China.
Lin Z; Jiangsu Youyuan Dairy Research Institute, Nanjing, 211100, Jiangsu, China.
Wang H; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China. .
Zhong J; Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology / Key Laboratory of Crop and Animal Integrated Farming, Ministry of Agriculture / Institute of Animal Science, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, Jiangsu, China. .
Pokaż więcej
Źródło:
Cell and tissue banking [Cell Tissue Bank] 2023 Mar; Vol. 24 (1), pp. 221-230. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Culture Techniques*
Feeder Cells*
Fibroblasts*
Mitomycin*/pharmacology
Pluripotent Stem Cells*/cytology
Cattle ; Cell Survival/drug effects ; Animals
Czasopismo naukowe
Tytuł:
Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer.
Autorzy:
Xie L; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China. Electronic address: .
Cheng L; State Key Laboratory of Materials-Oriented Chemical Engineering, College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China. Electronic address: .
Wei Y; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2023 Mar; Vol. 243, pp. 154350. Date of Electronic Publication: 2023 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*/pharmacology
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/metabolism
Humans ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; Apoptosis ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Cell Proliferation ; Apoptosis Regulatory Proteins
Czasopismo naukowe
Tytuł:
Systemic Interleukin-6 Response after Intravesical Instillation of Bacillus Calmette-Guérin and Mitomycin C in Superficial Bladder Cancer.
Autorzy:
Al-Humairi RMA; Department of Biology, College of Science for Women, University of Baghdad, Baghdad, Iraq.
Hashim Mohammad T; Department of Biology, College of Science for Women, University of Baghdad, Baghdad, Iraq.
Thanoon Ahmed S; Department of Biology, College of Science for Women, University of Baghdad, Baghdad, Iraq.
Ad'hiah AH; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq.
Pokaż więcej
Źródło:
Archives of Razi Institute [Arch Razi Inst] 2023 Feb 28; Vol. 78 (1), pp. 353-360. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Humans ; Administration, Intravesical ; BCG Vaccine ; Case-Control Studies ; Interleukin-6
Czasopismo naukowe
Tytuł:
ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts.
Autorzy:
Teplitsky JE; Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Vinokurtseva A; Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Armstrong JJ; Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Ivey Eye Institute, St. Joseph's Health Care, London, Ontario, Canada.
Denstedt J; Department of Ophthalmology, University of Ottawa, Ottawa, Ontario, Canada.
Liu H; Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Lawson Health Research Institute, London, Ontario, Canada.
Hutnik CML; Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Ivey Eye Institute, St. Joseph's Health Care, London, Ontario, Canada.; Lawson Health Research Institute, London, Ontario, Canada.
Pokaż więcej
Źródło:
Translational vision science & technology [Transl Vis Sci Technol] 2023 Feb 01; Vol. 12 (2), pp. 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mitomycin*/metabolism
Mitomycin*/pharmacology
Glaucoma*/surgery
Humans ; Tenon Capsule/metabolism ; Tenon Capsule/pathology ; Cicatrix/metabolism ; Matrix Metalloproteinase 9/metabolism ; Matrix Metalloproteinase 9/pharmacology ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Collagen
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies